Research on epitranscriptomics is shedding light on the mechanisms of normal and malignant hematopoiesis. Studies are investigating the roles of various factors, including METTL13 and METTL3, in the development and progression of certain types of cancer, such as leukemia. The findings may have implications for the development of targeted strategies for cancer immunotherapy and therapeutic potential.